BLOCK PAIN RECEPTORS WITH PROLEVIATE - AN OVERVIEW

Possessing recognized the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the event of NCP, including pain incidence, microglial activation, and inflammatory